- Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
-
Kim JO, Jun DW, Tae HJ, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC, Hahm JS
- KMID: 2155295
- Clin Mol Hepatol.
- 2015 Mar;21(1):85-88.
- doi: 10.3350/cmh.2015.21.1.85
Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation... -
- CITED
-
- Close
- SHARE
-
- Close
